{"id":41094,"date":"2026-01-30T07:00:15","date_gmt":"2026-01-30T12:00:15","guid":{"rendered":"https:\/\/www.ncqa.org\/?page_id=41094"},"modified":"2026-01-30T07:28:47","modified_gmt":"2026-01-30T12:28:47","slug":"cervical-cancer-screening-ccs-e","status":"publish","type":"page","link":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/cervical-cancer-screening-ccs-e\/","title":{"rendered":"Cervical Cancer Screening (CCS-E)"},"content":{"rendered":"<p><span data-contrast=\"auto\">The percentage of persons 21\u201364 years of age who were recommended for routine cervical cancer screening and were screened for cervical cancer using any of the following criteria:<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<ul>\n<li><span data-contrast=\"auto\">Persons 21\u201364 years of age who were recommended for routine cervical cancer screening and had cervical cytology performed within the last 3 years.<\/span><\/li>\n<li><span data-contrast=\"auto\">Persons 30\u201364 years of age who were recommended for routine cervical cancer screening and had cervical high-risk human papillomavirus (hrHPV) testing performed within the last 5 years.<\/span><\/li>\n<li><span data-contrast=\"auto\">Persons 30\u201364 years of age who were recommended for routine cervical cancer screening and had cervical cytology\/high-risk human papillomavirus (hrHPV) cotesting within the last 5 years.<\/span><\/li>\n<\/ul>\n<h2>Why It Matters?<\/h2>\n<p><span data-contrast=\"none\">Cervical cancer can be detected in its early stages by regular screening. Due to the success of cervical cancer screening in the U.S., dramatic decreases have been observed in both mortality and incidence of invasive cervical cancer. The current incidence rate is 6.9 cervical cancer cases per 100,000 women per year in the U.S., and the mortality rate associated with cervical cancer is 2.3 deaths per 100,000 per year <sup><a href=\"#ref-1\">1<\/a><\/sup>. The National Cancer Institute (NCI) estimated that there were 13,240 new cervical cancer cases and 4,170 related deaths in 2018 <sup><a href=\"#ref-2\">2<\/a><\/sup>.<\/span><\/p>\n<p><span data-contrast=\"none\">Human papillomavirus (HPV) causes virtually all cases of cervical cancer and associated precancerous lesions <sup><a href=\"#ref-3\">3<\/a><\/sup>. Cervical intraepithelial neoplasia, known as CIN, is a precancerous condition where abnormal cells are found on the surface of the cervix <sup><a href=\"#ref-4\">4<\/a><\/sup>. There are three stages of CIN, with the likelihood of becoming cancer and spreading to nearby normal tissues increasing from stage 1 to stage 3. Although vaccines to prevent most HPV infections that can cause cervical cancer are available, those who have been vaccinated should continue to be screened regularly <sup><a href=\"#ref-5\">5<\/a><\/sup>. Three screening strategies can detect cervical precancers and cancers: cytology testing, high-risk HPV (hrHPV) testing and cytology supplemented with HPV screening (cotesting).<\/span><\/p>\n<p><span data-contrast=\"none\">The US Preventive Services Task Force (USPSTF) recommends screening for cervical cancer every 3 years with cytology alone in women 21\u201329. Screening with hrHPV testing is not recommended for women younger than 30 because it results in more harms than benefits. The USPSTF recommends three cervical cancer screening strategies starting at age 30: cytology alone, hrHPV testing alone or cotesting every 5 years <sup><a href=\"#ref-6\">6<\/a><\/sup>. The USPSTF notes that the recommendation statement applies to all asymptomatic individuals with a cervix. The American Cancer Society (ACS) similarly recommend cervical cancer screening for all individuals with a cervix <sup><a href=\"#ref-3\">3<\/a><\/sup>. Additional guidelines from the University of California San Francisco Center of Excellence for Transgender Health <sup><a href=\"#ref-7\">7<\/a><\/sup>, World Professional Association for Transgender Health <sup><a href=\"#ref-8\">8<\/a><\/sup> and The Fenway Institute <sup><a href=\"#ref-9\">9<\/a><\/sup> recommend applying screening guidelines for cisgender women to transgender and gender diverse individuals with a cervix.<\/span><\/p>\n<h2>Historical Results \u2013 National Averages<\/h2>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The percentage of persons 21\u201364 years of age who were recommended for routine cervical cancer screening and were screened for cervical cancer using any of the following criteria:\u00a0 Persons 21\u201364 years of age who were recommended for routine cervical cancer screening and had cervical cytology performed within the last 3 years. Persons 30\u201364 years of [&hellip;]<\/p>\n","protected":false},"author":45,"featured_media":0,"parent":733,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page.php","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-41094","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cervical Cancer Screening (CCS-E) - NCQA<\/title>\n<meta name=\"description\" content=\"Learn about NCQA\u2019s Cervical Cancer Screening (CCS\u2011E) measure, screening criteria for ages 21\u201364, and why regular cervical cytology and HPV tests are essential for reducing cervical cancer incidence and mortality.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/cervical-cancer-screening-ccs-e\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cervical Cancer Screening (CCS-E) - NCQA\" \/>\n<meta property=\"og:description\" content=\"Learn about NCQA\u2019s Cervical Cancer Screening (CCS\u2011E) measure, screening criteria for ages 21\u201364, and why regular cervical cytology and HPV tests are essential for reducing cervical cancer incidence and mortality.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/cervical-cancer-screening-ccs-e\/\" \/>\n<meta property=\"og:site_name\" content=\"NCQA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/NCQA.org\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-30T12:28:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ncqa.org\/wp-content\/uploads\/2021\/04\/NCQA_cmyk_tag.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@NCQA\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/cervical-cancer-screening-ccs-e\/\",\"url\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/cervical-cancer-screening-ccs-e\/\",\"name\":\"Cervical Cancer Screening (CCS-E) - NCQA\",\"isPartOf\":{\"@id\":\"https:\/\/www.ncqa.org\/#website\"},\"datePublished\":\"2026-01-30T12:00:15+00:00\",\"dateModified\":\"2026-01-30T12:28:47+00:00\",\"description\":\"Learn about NCQA\u2019s Cervical Cancer Screening (CCS\u2011E) measure, screening criteria for ages 21\u201364, and why regular cervical cytology and HPV tests are essential for reducing cervical cancer incidence and mortality.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/cervical-cancer-screening-ccs-e\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/cervical-cancer-screening-ccs-e\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/cervical-cancer-screening-ccs-e\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ncqa.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Report Cards\",\"item\":\"https:\/\/www.ncqa.org\/report-cards\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Health Plans\",\"item\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"State of Health Care Quality Report\",\"item\":\"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/\"},{\"@type\":\"ListItem\",\"position\":5,\"name\":\"Cervical Cancer Screening (CCS-E)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ncqa.org\/#website\",\"url\":\"https:\/\/www.ncqa.org\/\",\"name\":\"NCQA\",\"description\":\"Measuring quality. Improving health care.\",\"publisher\":{\"@id\":\"https:\/\/www.ncqa.org\/#organization\"},\"alternateName\":\"National Committee for Quality Assurance\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ncqa.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ncqa.org\/#organization\",\"name\":\"NCQA\",\"alternateName\":\"National Committee for Quality Assurance\",\"url\":\"https:\/\/www.ncqa.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ncqa.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ncqa.org\/wp-content\/uploads\/NCQA-Blog-Logo-Thumbnail.jpg\",\"contentUrl\":\"https:\/\/www.ncqa.org\/wp-content\/uploads\/NCQA-Blog-Logo-Thumbnail.jpg\",\"width\":876,\"height\":673,\"caption\":\"NCQA\"},\"image\":{\"@id\":\"https:\/\/www.ncqa.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/NCQA.org\",\"https:\/\/x.com\/NCQA\",\"https:\/\/www.instagram.com\/ncqa_dc\/\",\"https:\/\/www.youtube.com\/@NcqaOrg\",\"https:\/\/www.linkedin.com\/company\/ncqa\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cervical Cancer Screening (CCS-E) - NCQA","description":"Learn about NCQA\u2019s Cervical Cancer Screening (CCS\u2011E) measure, screening criteria for ages 21\u201364, and why regular cervical cytology and HPV tests are essential for reducing cervical cancer incidence and mortality.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/cervical-cancer-screening-ccs-e\/","og_locale":"en_US","og_type":"article","og_title":"Cervical Cancer Screening (CCS-E) - NCQA","og_description":"Learn about NCQA\u2019s Cervical Cancer Screening (CCS\u2011E) measure, screening criteria for ages 21\u201364, and why regular cervical cytology and HPV tests are essential for reducing cervical cancer incidence and mortality.","og_url":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/cervical-cancer-screening-ccs-e\/","og_site_name":"NCQA","article_publisher":"https:\/\/www.facebook.com\/NCQA.org","article_modified_time":"2026-01-30T12:28:47+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.ncqa.org\/wp-content\/uploads\/2021\/04\/NCQA_cmyk_tag.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@NCQA","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/cervical-cancer-screening-ccs-e\/","url":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/cervical-cancer-screening-ccs-e\/","name":"Cervical Cancer Screening (CCS-E) - NCQA","isPartOf":{"@id":"https:\/\/www.ncqa.org\/#website"},"datePublished":"2026-01-30T12:00:15+00:00","dateModified":"2026-01-30T12:28:47+00:00","description":"Learn about NCQA\u2019s Cervical Cancer Screening (CCS\u2011E) measure, screening criteria for ages 21\u201364, and why regular cervical cytology and HPV tests are essential for reducing cervical cancer incidence and mortality.","breadcrumb":{"@id":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/cervical-cancer-screening-ccs-e\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/cervical-cancer-screening-ccs-e\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/cervical-cancer-screening-ccs-e\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ncqa.org\/"},{"@type":"ListItem","position":2,"name":"Report Cards","item":"https:\/\/www.ncqa.org\/report-cards\/"},{"@type":"ListItem","position":3,"name":"Health Plans","item":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/"},{"@type":"ListItem","position":4,"name":"State of Health Care Quality Report","item":"https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/"},{"@type":"ListItem","position":5,"name":"Cervical Cancer Screening (CCS-E)"}]},{"@type":"WebSite","@id":"https:\/\/www.ncqa.org\/#website","url":"https:\/\/www.ncqa.org\/","name":"NCQA","description":"Measuring quality. Improving health care.","publisher":{"@id":"https:\/\/www.ncqa.org\/#organization"},"alternateName":"National Committee for Quality Assurance","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ncqa.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ncqa.org\/#organization","name":"NCQA","alternateName":"National Committee for Quality Assurance","url":"https:\/\/www.ncqa.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ncqa.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.ncqa.org\/wp-content\/uploads\/NCQA-Blog-Logo-Thumbnail.jpg","contentUrl":"https:\/\/www.ncqa.org\/wp-content\/uploads\/NCQA-Blog-Logo-Thumbnail.jpg","width":876,"height":673,"caption":"NCQA"},"image":{"@id":"https:\/\/www.ncqa.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/NCQA.org","https:\/\/x.com\/NCQA","https:\/\/www.instagram.com\/ncqa_dc\/","https:\/\/www.youtube.com\/@NcqaOrg","https:\/\/www.linkedin.com\/company\/ncqa\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages\/41094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/users\/45"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/comments?post=41094"}],"version-history":[{"count":10,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages\/41094\/revisions"}],"predecessor-version":[{"id":49480,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages\/41094\/revisions\/49480"}],"up":[{"embeddable":true,"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/pages\/733"}],"wp:attachment":[{"href":"https:\/\/www.ncqa.org\/wp-json\/wp\/v2\/media?parent=41094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}